Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Sarcoma 1 Recurrent Malignant Solid Neoplasm 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Malignant Neoplasms of Digestive Organs 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Liver Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumor 1

Interventions

Carboplatin 75 Paclitaxel 68 Bevacizumab 44 Taxes 22 Cyclophosphamide 21 pembrolizumab 19 Gemcitabine 19 Cisplatin 18 Topotecan 17 Hyperthermic Intraperitoneal Chemotherapy 14 olaparib 13 liposomal doxorubicin 13 Immunoglobulin G 13 Disulfides 13 Specimen Handling 11 Drug Therapy 11 niraparib 10 Cytoreduction Surgical Procedures 10 Magnetic Resonance Spectroscopy 9 sargramostim 7 Surveys and Questionnaires 7 Doxorubicin 7 Docetaxel 7 durvalumab 6 Platinum 6 Nivolumab 6 Letrozole 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 Biopsy 6 Albumin-Bound Paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fallopian Tube Neoplasms × sapanisertib × Clear all

NCT03648489 2024-09-20

DICE

Imperial College London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡